Improved Myeloma Targeting by Combination of the Human Anti-CD38 Antibody Daratumumab with Lenalidomide and Bortezomib

M.S. van der Veer; M. de Weers; B. van Kessel - Welmers; J.M. Bakker; S. Wittebol; P.W.H.I. Parren; H.M. Lokhorst; T. Mutis

Improved Myeloma Targeting by Combination of the Human Anti-CD38 Antibody Daratumumab with Lenalidomide and Bortezomib

M.S. van der Veer, M. de Weers, B. van Kessel - Welmers, J.M. Bakker, S. Wittebol, P.W.H.I. Parren, H.M. Lokhorst, T. Mutis

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Pages	34-34
Number of pages	1
Publication status	Published - 2011
Event	Unknown event - Duration: 26 Aug 2014 → 30 Aug 2014

Conference

Conference	Unknown event
Period	26/08/14 → 30/08/14

Cite this

@conference{ac5605c87dbe4e46a0191451ab2f8656,

title = "Improved Myeloma Targeting by Combination of the Human Anti-CD38 Antibody Daratumumab with Lenalidomide and Bortezomib",

author = "{van der Veer}, M.S. and {de Weers}, M. and {van Kessel - Welmers}, B. and J.M. Bakker and S. Wittebol and P.W.H.I. Parren and H.M. Lokhorst and T. Mutis",

year = "2011",

language = "English",

pages = "34--34",

note = "Unknown event ; Conference date: 26-08-2014 Through 30-08-2014",

}

TY - CONF

T1 - Improved Myeloma Targeting by Combination of the Human Anti-CD38 Antibody Daratumumab with Lenalidomide and Bortezomib

AU - van der Veer, M.S.

AU - de Weers, M.

AU - van Kessel - Welmers, B.

AU - Bakker, J.M.

AU - Wittebol, S.

AU - Parren, P.W.H.I.

AU - Lokhorst, H.M.

AU - Mutis, T.

PY - 2011

Y1 - 2011

M3 - Abstract

SP - 34

EP - 34

T2 - Unknown event

Y2 - 26 August 2014 through 30 August 2014

ER -